Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $23,551,110 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 150 grants at over 100 hospitals in 17 countries.
![](/media/3148/suzanne_baker.jpg)
St. Jude's Children's Research Hospital - $15,000
$15,000.00
October 2012
Establishment and Characterization of Renewable Tissue Resources for DIPG Research
![](/media/3418/dipgdmg_registry_logo.png)
DIPG Registry - $219,000
$219,000.00
January 2012
Establishment of an International DIPG Registry
![](/media/3136/xiao-nan_li.jpg)
Texas Children's Cancer Center - $100,000
$100,000.00
November 2011
Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001
![](/media/3127/oren_becher.jpg)
Duke University - $82,049
$82,049.00
November 2011
Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody
![](/media/3150/charles_keller.jpg)
Doernbecher Children's Hospital - $100,000
$100,000.00
November 2011
Rapid Preclinical Development of a Targeted Therapy Combination for DIPG.
![](/media/3149/david_ziegler.jpg)
Sydney Children's Hospital - $100,000
$100,000.00
August 2011
Robotic screening for novel therapies for diffuse pontine gliomas
![](/media/3148/suzanne_baker.jpg)
St. Jude's Children's Research Hospital - $35,000
$35,000.00
September 2010
PI3K signaling effectors in DIPG
![](/media/3151/lionel_chow.jpg)
Cincinnati Children's Hospital - $35,000
$35,000.00
September 2010
Establishment of a pre-clinical model for pediatric glioblastoma
![](/media/3152/rachid_drissi.jpg)
Cincinnati Children's Hospital - $75,000
$75,000.00
March 2010
Telomerase: A Therapeutic Target in Pediatric Brain Tumors
![](/media/3153/mark_souweidane.jpg)
Weill Cornell Medical College - $91,740
$91,740.00
March 2010
Phase I Study of tumor-targeting Convection-Enhanced Delivery (CED) of radio immunotherapy for Diffuse Pontine Glioma in Children.
![](/media/3154/alberto_broniscer.jpg)
St. Jude's Children's Research Hospital - $10,000
$10,000.00
July 2009
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.
![](/media/3128/maryam_fouladi.png)
Cincinnati Children's Hospital - $50,000
$50,000.00
July 2009
National expansion of the study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
![](/media/3154/alberto_broniscer.jpg)
St. Jude's Children's Research Hospital - $50,000
$50,000.00
July 2009
Phase I Study of the combination of Vandetanib and Dasatinib administered during and after radiation therapy in the children with newly diagnosed DIPG.
![](/media/3128/maryam_fouladi.png)
Cincinnati Children's Hospital - $50,000
$50,000.00
September 2008
Study of Radiotherapy and concurrent Bevacizumab +/- Temozolamide followed by Bevacizumab, Irinotecan +/- Temozolamide in patients with newly diagnosed high grade gliomas and DIPG.
![](/media/3154/alberto_broniscer.jpg)
St. Jude's Children's Research Hospital - $25,000
$25,000.00
September 2008
Molecular Analysis of Diffuse Intrinsic Pontine Gliomas.